Substance use disorders are relatively common in primary care settings. Can busy physicians accurately detect them with just one question?

A new study may lead to better drug tests that can distinguish between heroin use and the ingestion of poppy seeds, such as on a bagel or in salad dressing.

The Substance Abuse and Mental Health Services Administration (SAMHSA) sent out an alert in February to addiction treatment professionals warning of an increase in deaths since the beginning of the year that are reportedly linked to heroin containing fentanyl.

The American Society of Addiction Medicine (ASAM) has developed standards of care for physicians who treat patients with substance use disorders.

The Transtheoretical Model (TTM) of behavior change has become almost universally accepted in addiction treatment. Like all dogmas, it is rarely critically examined, leading to blind belief and unskilled use.

Chronic care management (CCM), used successfully to treat other chronic diseases such as diabetes and cardiovascular disease, is one approach being looked at to improve care and clinical outcomes for patients with addiction.

Can electronic cigarettes, commonly referred to as e-cigarettes, play a role in helping people quit smoking tobacco?

A coalition, formed to fight what it sees as an opioid epidemic, is rallying support against the US Food and Drug Administration’s (FDA) approval of the drug Zohydro.

Fingerprint biometrics may be coming to an addiction treatment program near you.

About 1.6 million Americans use cocaine every year, and roughly one-quarter of them meet diagnostic criteria for a cocaine use disorder (CUD) under DSM-5 criteria. Fortunately, CUD responds to many of the same psychosocial interventions as other substance use disorders.